Haemolytic activity of liposomes: Effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation

Journal of Biomedical Nanotechnology

Volumn 5, Issue 4, 2009, Pages 409-415

  Mourtas, Spyridon ^a   Michanetzis, Georgios P A K ^b   Missirlis, Yannis F ^b   Antimisiaris, Sophia G ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c INSTITUTE OF COMPUTER SCIENCE   (Greece)

Author keywords

Arsenic; Arsonolipids; Arsonoliposomes; Blood; Erythrocytes; Haemolysis; Liposomes; PEG lipids; PEGylation

Indexed keywords

ARSONOLIPOSOMES; BLOOD ERYTHROCYTES; DRUG ADMINISTRATION; HAEMOLYSIS; HUMAN RED BLOOD CELL; LIPID CONCENTRATION; LIPID MEMBRANES; MULTI-LAMELLAR VESICLES; PEGYLATION; PROBE SONICATION; RED BLOOD CELL SUSPENSION; VESICLE SIZE;

ARSENIC; CELL CULTURE; CELLS; CONCENTRATION (PROCESS); DISPERSIONS; FILM PREPARATION; HEMOGLOBIN OXYGEN SATURATION; LIPOSOMES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; THERMOPLASTICS;

BLOOD;

ANTIPARASITIC AGENT; LIPID; LIPOSOME; MACROGOL 2000; PHOSPHOLIPID; POLYETHYLENE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; CYTOTOXICITY TEST; HEMODYNAMICS; HEMOLYSIS; HUMAN; NONHUMAN; PARTICLE SIZE;

CELL SIZE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HEMOLYSIS; HUMANS; LIPIDS; POLYETHYLENE GLYCOLS; UNILAMELLAR LIPOSOMES;

EID: 70450158725     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.1050     Document Type: Article

References (22)

1. G. P. A. K. Michanetzis, Y. F. Missirlis, and S. G. Antimisiaris, Haemocompatibility of nanosized drug delivery systems: Has it been adequately considered? J. Biomed. Nanotechnol. 4, 218 (2008).
2. D. Fatouros, P. V. Ioannou, and S. G. Antimisiaris, Novel nanosized arsenic containing vesicles for drug delivery: Arsonoliposomes. J. Nanoscience Nanotechnol. 6, 2618 (2006).
3. S. G. Antimisiaris, Arsonoliposomes for drug delivery. J. Drug Deli. Sci. Technol. 17, 377 (2007).
4. J. C. Saha, A. K. Dikshit, M. Bandyopadhyay, and K. C. Saha, A review of arsenic poisoning and its effects on human health. Crit. Rev. Environ. Sci. Technol. 29, 281 (1999).
5. S. L. Winski, D. S. Barber, L. T. Rael, and D. E. Carter, Sequence of toxic events in arsine-induced haemolysis in vitro: Implications for the mechanism of toxicity in human erythrocytes. Fund. Appl. Toxicol. 38, 123 (1997).
6. D. Biswas, M. Banerjee, G. Sen, J. K. Das, A. Banerjee, T. J. Sau, S. Pandit, A. K. Giri, and T. Biswas, Mechanism of erythrocyte death in human population exposed to arsenic through drinking water. Toxicol. Appl. Pharmacol. 230, 57 (2008).
7. H. Mahmud, M. Föller, and F. Lang, Arsenic-induced suicidal erythrocyte death. Arch. Toxicol. 83, 107 (2009).
8. G. M. Tsivgoulis, D. N. Sotiropoulos, and P. V. Ioannou, 1,2.Dihydroxypropyl-3-arsonic acid: A key intermediate for arsonolipids. Phosphorus, Sulfur, and Silicon 57, 189 (1991).
9. G. M. Tsivgoulis, D. N. Sotiropoulos, and P. V. Ioannou, Rac-1,2-Diacylo-xypropyl-3-arsonic acids: Arsonolipid analogues of phosphonolipids. Phosphorous, Sulfur, and Silicon 63, 329 (1991).
10. S. V. Serves, D. N. Sotiropoulos, P. V. Ioannou, and M. K. Jain, Synthesis of (R)-and (S)-1,2-diacyloxypropyl-3-arsonic acids: Optically active arsonolipids. Phosphorous, Sulfur, and Silicon 71, 99 (1992).
11. S. V. Serves, D. N. Sotiropoulos, P. V. Ioannou, and M. K. Jain, One pot synthesis of arsonolipid via thioarsenite precursors. Phosphorous, Sulfur, and Silicon 81, 181 (1993).
12. G. M. Tsivgoulis and P. V. Ioannou, A reinvestigation of the synthesis of arsonolipids (2,3-diacyloxypropylarsonic acids). Chem. Phys. Upids 152, 113 (2008).
13. A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238 (1965).
14. J. C. M. Stewart, Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104, 10 (1980).
15. D. Fatouros, O. Gortzi, P. Klepetsanis, S. G. Antimisiaris, M. C. A. Stuart, A. Brisson, and P. V. Ioannou, Preparation and properties of arsonolipid containing liposomes. Chem. Phys. Lipids 109, 75 (2001).
16. W. R. Perkins, R. B. Dause, X. Li, J. C. Franklin, D. J. Cabral-Lilly, Y. Zha, E. H. Dank, and A. S. Janoff, Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its haemolytic activity. Biochim. Biophys. Acta - Biomembranes 1327, 61 (1997).
17. M. Jumaa and B. W. Müller, Lipid emulsions as a novel system to reduce the haemolytic activity of lytic agents: Mechanism of the protective effect. Eur. J. Pharm. Sci. 9, 285 (2000).
18. L. N. Yuldasheva, E. B. Carvalho, M.-T. J. A. Catanho, and O. V. Krasilnikov, Cholesterol-dependent haemolytic activity of Passiflora quadrangularis leaves. Braz. J. Med. Biol. Res. 38, 1061 (2005).
19. H. Matsuyama, M. Tomita, R. Taguchi, and H. Ikezawa, Alteration in reactivity of sphingomyelinase from Streptomyces sp. modified with a polyethylene glycol derivative. Biol. Pharm. Bull. 16, 107 (1993).
20. D. G. Fatouros, N. Bouropoulos, P. V. Ioannou, and S. G. Antimisiaris, Stability and aggregation studies of non-sonicated arsonolipid-containing vesicles. Cell Mol. Biol. Lett. 10, 173 (2005).
21. D. G. Fatouros, S. Piperoudi, O. Gortzi, P. V. Ioannou, and S. G. Antimisiaris, Physical stability of sonicated arsonoliposomes: Effect of calcium ions. J. Pharm. Sci-US 94, 46 (2005).
22. S. Piperoudi, D. Fatouros, P. V. Ioannou, P. Frederik, and S. G. Antimisiaris, Incorporation of PEG-lipids in arsonoliposomes can produce highly stable arsenic-containing vesicles of specific lipid composition. Chem. Phys. Lipids 139, 96 (2006).